ARLENE BRITT: Open Payments
NPI 1528154010 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 20 payments from 10 companies in 2025. Trend: 2023 $73 · 2024 $229 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $241 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Abbott Laboratories | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: CAPLYTA, UZEDY, INVEGA SUSTENNA, ETERNA, ZENPEP, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across NC — which companies pay providers there.
